Home Page

On Aug. 12, BRET hosted an orientation for incoming graduate students, welcoming the new cohort and putting together a comprehensive agenda with useful information regarding their future training at Vanderbilt and beyond. Read More

The Poster Printing Core is back from hiatus. Read More

For researchers, projects can sometimes feel like babies, and there is nothing more satisfying than seeing your baby grow up. For William Tansey, professor of cell and developmental biology, this baby started 10 years ago when he and Stephen Fesik, Orrin H. Ingram II, Professor of Cancer Research and professor of biochemistry, discovered that a protein called WDR5 is a “partner in crime” to MYC, a transcription factor and oncogene that is often mutated in cancers. In fact, dysregulation of MYC is estimated to be responsible for about a third of all cancer deaths annually. Read More

Through his work, Neil Osheroff reaches medical students at Vanderbilt and around the globe with his innovative ideas. Read More

Days’ work to identify highly potent and selective 5-HT2B antagonists was recognized by the Rosalind Franklin Society Read More

The Chazin lab used a combination of nuclear magnetic resonance spectroscopy, isothermal titration calorimetry, computational modelling, and cell-based techniques are used to interrogate the relationship between NEIL1 and RPA. Read More

At a recent Center for Applied AI in Protein Dynamics seminar, Christian Mayr of Technische Universität Dresden discussed how new hardware technologies will transform AI development and allow machines to mimic the efficiency and processing power of the human brain. Read More

Alissa Weaver, professor of cell and developmental biology, was honored for her work on a paper published in Developmental Cell titled “VAP-A and its binding partner CERT drive biogenesis of RNA-containing extracellular vesicles at ER membrane contact sites.” Read More

Science Immunology study suggests a new class of inborn errors of immunometabolism and could improve care for patients with these complex diseases. Read More

Gary Sulikowski, Stevenson Professor of Chemistry, was named director of the Vanderbilt Institute for Chemical Biology in 2017. Since then, he has stewarded VICB’s growth and research operations. He shares how VICB has contributed to translational research, some of the research he's most excited about, and what makes Vanderbilt a rare place where powerful collaborative research can achieve its potential. Read More